Analysis of Cost and Treatment Effects in the Care Given for Graves' Disease: A Swedish Cost–Utility Analysis
ABSTRACT Background Guidelines in healthcare should be evidence‐based, satisfy patient needs and improve patient outcome. Methods We performed a cost–utility analysis in Graves' disease (GD) and estimated incremental costs after the introduction of a national guideline adding the Graves' R...
Saved in:
| Main Authors: | Lars Lindholm, Gabriel Sjölin, Annika Jonsson, Mirna Abraham‐Nordling, Göran Wallin, TT‐12 Study Group, Helena Filipsson Nyström |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Endocrinology, Diabetes & Metabolism |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/edm2.70034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа
by: A. Yu. Kulikov, et al.
Published: (2015-03-01) -
Cost-effectiveness study of the MitraClip system for mitral regurgitation treatment in inoperable patients
by: E. G. Fedina, et al.
Published: (2021-09-01) -
International experience in determining the cost-effectiveness thresholds
by: T. P. Bezdenezhnykh, et al.
Published: (2019-01-01) -
Cost utility analysis of antibiotics compared with operative treatment in uncomplicated acute appendicitis
by: Napaphat Poprom, et al.
Published: (2025-04-01) -
Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021-02-01)